Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Aug;109(4):1120–1127. doi: 10.1111/j.1476-5381.1993.tb13738.x

Pharmacological characterization of acetylcholine-stimulated [35S]-GTP gamma S binding mediated by human muscarinic m1-m4 receptors: antagonist studies.

S Lazareno 1, N J Birdsall 1
PMCID: PMC2175752  PMID: 8401923

Abstract

1. We have used dose-ratio analysis to estimate functionally the affinity constants (pKb) and Schild slope factors of a range of selective or atypical antagonists at human muscarinic m1-m4 receptors. 2. The functional response was the stimulation by acetylcholine of [35S]-GTP gamma S binding to membranes from Chinese hamster ovary (CHO) cells stably expressing individual receptor subtypes. 3. A novel experimental design and analysis was used which allowed the estimation of affinity and Schild slope factor from a single antagonist inhibition curve, and the results were compared with other methods of analysis, both theoretically valid and invalid. 4. In general, the affinity estimates were very similar to previously reported values obtained in binding studies with animal tissues and cloned human receptors and the Schild slope factors were close to unity. 5. These results demonstrate the validity of the assay and provide no evidence for species differences in antagonist affinity for muscarinic receptor subtypes. 6. The results confirm both the utility of himbacine in distinguishing between m1 and m4 receptors and a previously reported modest m4-selectivity for tropicamide and secoverine. 7. The cholinesterase inhibitor, tacrine (THA), had a potency profile similar to that of gallamine but with less selectivity. Its affinity could not be determined since it had Schild slope factors of about 2 at all subtypes. 8. o-Methoxy-sila-hexocyclium had only a modest selectivity for the m1 subtype.

Full text

PDF
1120

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashkenazi A., Peralta E. G., Winslow J. W., Ramachandran J., Capon D. J. Functionally distinct G proteins selectively couple different receptors to PI hydrolysis in the same cell. Cell. 1989 Feb 10;56(3):487–493. doi: 10.1016/0092-8674(89)90251-1. [DOI] [PubMed] [Google Scholar]
  2. Ashkenazi A., Winslow J. W., Peralta E. G., Peterson G. L., Schimerlik M. I., Capon D. J., Ramachandran J. An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover. Science. 1987 Oct 30;238(4827):672–675. doi: 10.1126/science.2823384. [DOI] [PubMed] [Google Scholar]
  3. Bernheim L., Mathie A., Hille B. Characterization of muscarinic receptor subtypes inhibiting Ca2+ current and M current in rat sympathetic neurons. Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9544–9548. doi: 10.1073/pnas.89.20.9544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berstein G., Blank J. L., Jhon D. Y., Exton J. H., Rhee S. G., Ross E. M. Phospholipase C-beta 1 is a GTPase-activating protein for Gq/11, its physiologic regulator. Cell. 1992 Aug 7;70(3):411–418. doi: 10.1016/0092-8674(92)90165-9. [DOI] [PubMed] [Google Scholar]
  5. Bourne H. R., Stryer L. G proteins. The target sets the tempo. Nature. 1992 Aug 13;358(6387):541–543. doi: 10.1038/358541a0. [DOI] [PubMed] [Google Scholar]
  6. Buckley N. J., Bonner T. I., Buckley C. M., Brann M. R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol. 1989 Apr;35(4):469–476. [PubMed] [Google Scholar]
  7. Caulfield M. P., Brown D. A. Pharmacology of the putative M4 muscarinic receptor mediating Ca-current inhibition in neuroblastoma x glioma hybrid (NG 108-15) cells. Br J Pharmacol. 1991 Sep;104(1):39–44. doi: 10.1111/j.1476-5381.1991.tb12381.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cerione R. A. Reconstitution of receptor/GTP-binding protein interactions. Biochim Biophys Acta. 1991 Dec 12;1071(4):473–501. doi: 10.1016/0304-4157(91)90007-j. [DOI] [PubMed] [Google Scholar]
  9. Cheng Y., Prusoff W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
  10. Chidiac P., Wells J. W. Effects of adenyl nucleotides and carbachol on cooperative interactions among G proteins. Biochemistry. 1992 Nov 10;31(44):10908–10921. doi: 10.1021/bi00159a035. [DOI] [PubMed] [Google Scholar]
  11. Clark A. L., Mitchelson F. The inhibitory effect of gallamine on muscarinic receptors. Br J Pharmacol. 1976 Nov;58(3):323–331. doi: 10.1111/j.1476-5381.1976.tb07708.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Costa T., Ogino Y., Munson P. J., Onaran H. O., Rodbard D. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol Pharmacol. 1992 Mar;41(3):549–560. [PubMed] [Google Scholar]
  13. DeLean A., Munson P. J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol. 1978 Aug;235(2):E97–102. doi: 10.1152/ajpendo.1978.235.2.E97. [DOI] [PubMed] [Google Scholar]
  14. Dörje F., Levey A. I., Brann M. R. Immunological detection of muscarinic receptor subtype proteins (m1-m5) in rabbit peripheral tissues. Mol Pharmacol. 1991 Oct;40(4):459–462. [PubMed] [Google Scholar]
  15. Dörje F., Wess J., Lambrecht G., Tacke R., Mutschler E., Brann M. R. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther. 1991 Feb;256(2):727–733. [PubMed] [Google Scholar]
  16. Ehlert F. J. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium. J Pharmacol Exp Ther. 1988 Nov;247(2):596–602. [PubMed] [Google Scholar]
  17. Florio V. A., Sternweis P. C. Mechanisms of muscarinic receptor action on Go in reconstituted phospholipid vesicles. J Biol Chem. 1989 Mar 5;264(7):3909–3915. [PubMed] [Google Scholar]
  18. Ford A. P., Eglen R. M., Whiting R. L. Analysis of muscarinic cholinoceptors mediating phosphoinositide hydrolysis in guinea pig cardiac muscle. Eur J Pharmacol. 1992 Feb 13;225(2):105–112. doi: 10.1016/0922-4106(92)90089-e. [DOI] [PubMed] [Google Scholar]
  19. GADDUM J. H. Theories of drug antagonism. Pharmacol Rev. 1957 Jun;9(2):211–218. [PubMed] [Google Scholar]
  20. Hilf G., Gierschik P., Jakobs K. H. Muscarinic acetylcholine receptor-stimulated binding of guanosine 5'-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes. Eur J Biochem. 1989 Dec 22;186(3):725–731. doi: 10.1111/j.1432-1033.1989.tb15266.x. [DOI] [PubMed] [Google Scholar]
  21. Hilf G., Jakobs K. H. Agonist-independent inhibition of G protein activation by muscarinic acetylcholine receptor antagonists in cardiac membranes. Eur J Pharmacol. 1992 Mar 12;225(3):245–252. doi: 10.1016/0922-4106(92)90026-r. [DOI] [PubMed] [Google Scholar]
  22. Hilf G., Kupprion C., Wieland T., Jakobs K. H. Dissociation of guanosine 5'-[gamma-thio]triphosphate from guanine-nucleotide-binding regulatory proteins in native cardiac membranes. Regulation by nucleotides and muscarinic acetylcholine receptors. Eur J Biochem. 1992 Mar 1;204(2):725–731. doi: 10.1111/j.1432-1033.1992.tb16687.x. [DOI] [PubMed] [Google Scholar]
  23. Hulme E. C., Birdsall N. J., Buckley N. J. Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol. 1990;30:633–673. doi: 10.1146/annurev.pa.30.040190.003221. [DOI] [PubMed] [Google Scholar]
  24. Jones S. V., Heilman C. J., Brann M. R. Functional responses of cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol. 1991 Aug;40(2):242–247. [PubMed] [Google Scholar]
  25. Katz A., Wu D., Simon M. I. Subunits beta gamma of heterotrimeric G protein activate beta 2 isoform of phospholipase C. Nature. 1992 Dec 17;360(6405):686–689. doi: 10.1038/360686a0. [DOI] [PubMed] [Google Scholar]
  26. Kenakin T., Boselli C. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea. J Pharmacol Exp Ther. 1989 Sep;250(3):944–952. [PubMed] [Google Scholar]
  27. Kiefer-Day J. S., Campbell H. E., Towles J., el-Fakahany E. E. Muscarinic subtype selectivity of tetrahydroaminoacridine: possible relationship to its capricious efficacy. Eur J Pharmacol. 1991 Oct 22;203(3):421–423. doi: 10.1016/0014-2999(91)90901-2. [DOI] [PubMed] [Google Scholar]
  28. Kurose H., Katada T., Haga T., Haga K., Ichiyama A., Ui M. Functional interaction of purified muscarinic receptors with purified inhibitory guanine nucleotide regulatory proteins reconstituted in phospholipid vesicles. J Biol Chem. 1986 May 15;261(14):6423–6428. [PubMed] [Google Scholar]
  29. Lambrecht G., Gmelin G., Rafeiner K., Strohmann C., Tacke R., Mutschler E. o-Methoxy-sila-hexocyclium: a new quaternary M1-selective muscarinic antagonist. Eur J Pharmacol. 1988 Jun 22;151(1):155–156. doi: 10.1016/0014-2999(88)90708-x. [DOI] [PubMed] [Google Scholar]
  30. Lazareno S., Birdsall N. J. Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations. Br J Pharmacol. 1993 Aug;109(4):1110–1119. doi: 10.1111/j.1476-5381.1993.tb13737.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lazareno S., Buckley N. J., Roberts F. F. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells. Mol Pharmacol. 1990 Dec;38(6):805–815. [PubMed] [Google Scholar]
  32. Lazareno S., Farries T., Birdsall N. J. Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors m1-m4. Life Sci. 1993;52(5-6):449–456. doi: 10.1016/0024-3205(93)90301-i. [DOI] [PubMed] [Google Scholar]
  33. Liebmann C., Nawrath S., Schnittler M., Schubert H., Jakobs K. H. Binding characteristics and functional G protein coupling of muscarinic acetylcholine receptors in rat duodenum smooth muscle membranes. Naunyn Schmiedebergs Arch Pharmacol. 1992 Jan;345(1):7–15. doi: 10.1007/BF00175462. [DOI] [PubMed] [Google Scholar]
  34. McKinney M., Anderson D. J., Vella-Rountree L., Connolly T., Miller J. H. Pharmacological profiles for rat cortical M1 and M2 muscarinic receptors using selective antagonists: comparison with N1E-115 muscarinic receptors. J Pharmacol Exp Ther. 1991 Jun;257(3):1121–1129. [PubMed] [Google Scholar]
  35. Michel A. D., Delmendo R. E., Lopez M., Whiting R. L. On the interaction of gallamine with muscarinic receptor subtypes. Eur J Pharmacol. 1990 Jul 3;182(2):335–345. doi: 10.1016/0014-2999(90)90292-e. [DOI] [PubMed] [Google Scholar]
  36. Mitchelson F. Muscarinic receptor differentiation. Pharmacol Ther. 1988;37(3):357–423. doi: 10.1016/0163-7258(88)90005-8. [DOI] [PubMed] [Google Scholar]
  37. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  38. Nathanson N. M. Molecular properties of the muscarinic acetylcholine receptor. Annu Rev Neurosci. 1987;10:195–236. doi: 10.1146/annurev.ne.10.030187.001211. [DOI] [PubMed] [Google Scholar]
  39. Pfaffinger P. J., Martin J. M., Hunter D. D., Nathanson N. M., Hille B. GTP-binding proteins couple cardiac muscarinic receptors to a K channel. Nature. 1985 Oct 10;317(6037):536–538. doi: 10.1038/317536a0. [DOI] [PubMed] [Google Scholar]
  40. Potter L. T., Ferrendelli C. A., Hanchett H. E., Hollifield M. A., Lorenzi M. V. Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors. Mol Pharmacol. 1989 May;35(5):652–660. [PubMed] [Google Scholar]
  41. Pöch G., Brunner F., Kühberger E. Construction of antagonist dose-response curves for estimation of pA2-values by Schild-plot analysis and detection of allosteric interactions. Br J Pharmacol. 1992 Jul;106(3):710–716. doi: 10.1111/j.1476-5381.1992.tb14399.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Shiozaki K., Haga T. Effects of magnesium ion on the interaction of atrial muscarinic acetylcholine receptors and GTP-binding regulatory proteins. Biochemistry. 1992 Nov 3;31(43):10634–10642. doi: 10.1021/bi00158a028. [DOI] [PubMed] [Google Scholar]
  43. Tietje K. M., Goldman P. S., Nathanson N. M. Cloning and functional analysis of a gene encoding a novel muscarinic acetylcholine receptor expressed in chick heart and brain. J Biol Chem. 1990 Feb 15;265(5):2828–2834. [PubMed] [Google Scholar]
  44. Waelbroeck M., Tastenoy M., Camus J., Christophe J. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain. Mol Pharmacol. 1990 Aug;38(2):267–273. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES